Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
3.2 Clinical medicine, Expert, Latvian Council of Science
9 May 2024 → 8 May 2027
3.2 Clinical medicine, Expert, Latvian Council of Science
2 Sept 2021 → 1 Sept 2024
3.2 Clinical medicine, Expert, Latvian Council of Science
1 Oct 2018 → 30 Sept 2021
Field of Science
- 3.2 Clinical medicine
Fingerprint
Dive into the research topics where Iveta Ozere is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Rational use of pyrazinamide in the treatment of tuberculosis based on resistance determining M.tuberculosis gene mutations diagnostic and specific metabolism of the patient.
Vīksna, A. (Project leader) & Ozere, I. (Supervisor)
1/10/18 → 30/09/24
Project: PhD projects
-
Dynamics of serum cytokines in patients with pulmonary tuberculosis
Eglīte, J. (Project leader), Koļesova, O. (Participant), Ozere, I. (Participant) & Vīksna, A. (Participant)
1/08/20 → 31/07/21
Project: RSU grants
-
Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships
Ulanova, V., Kivrane, A., Viksna, A., Pahirko, L., Freimane, L., Sadovska, D., Ozere, I., Cirule, A., Sevostjanovs, E., Grinberga, S., Bandere, D. & Ranka, R. (Corresponding Author), Mar 2024, In: Frontiers in Pharmacology. 15, 20 p., 1332752.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)10 Downloads (Pure) -
Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective
Kivrane, A. (Corresponding Author), Ulanova, V., Grinberga, S., Sevostjanovs, E., Viksna, A., Ozere, I., Bogdanova, I., Zolovs, M. & Ranka, R., 12 Mar 2024, In: Pharmaceutics. 16, 3, 388.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Downloads (Pure) -
Unraveling tuberculosis patient cluster transmission chains: integrating WGS-based network with clinical and epidemiological insights
Sadovska, D. (Corresponding Author), Ozere, I., Pole, I., Ķimsis, J., Vaivode, A., Vīksna, A., Norvaiša, I., Bogdanova, I., Ulanova, V., Čapligina, V., Bandere, D. & Ranka, R., 2024, In: Frontiers in Public Health. 12, 1378426.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Downloads (Pure) -
Advantages of analysing both pairwise SNV-distance and differing SNVs between Mycobacterium tuberculosis isolates for recurrent tuberculosis cause determination.
Sadovska, D. (Corresponding Author), Nodieva, A., Pole, I., Ķimsis, J., Vīksna, A., Ozere, I., Norvaiša, I., Bandere, D. & Ranka, R., 1 Mar 2023, In: Microbial genomics. 9, 3, 15 p., 000956.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)7 Downloads (Pure) -
ANALYSIS OF SINGLE ACCUMULATED NUCLEOTIDE VARIANTS AND MUTATION RATE IN M. TUBERCULOSIS ISOLATE PAIRS USING THE WHOLE GENOME SEQUENCING APPROACH
Sadovska, D., Vīksna, A., Ozere, I., Norvaiša, I. & Ranka, R., 2023, In: Medicina (Kaunas). 59, Suppl.2, p. 348 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access
Activities
-
Analysis of Single Accumulated Nucleotide Variants and Mutation Rate in M. tuberculosis Isolate Pairs Using the Whole Genome Sequencing Approach
Sadovska, D. (Speaker), Vīksna, A. (Co-author), Ozere, I. (Co-author), Norvaiša, I. (Co-author) & Ranka, R. (Co-author)
29 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Assessment of Rifampicin Exposure in Latvian Pulmonary Tuberculosis Patients in the Context with AADAC Genetic Polymorphisms
Kivrāne, A. (Speaker), Ulanova, V. (Co-author), Grinberga, S. (Co-author), Sevostjanovs, E. (Co-author), Vīksna, A. (Co-author), Pole, I. (Co-author), Ozere, I. (Co-author), Bogdanova, I. (Co-author), Zolovs, M. (Co-author), Bandere, D. (Co-author) & Ranka, R. (Co-author)
29 Mar 2023Activity: Talk or presentation types › Poster presentation
-
RSU konference “Praktiskā infektoloģija - šeit un šodien”
Savicka, O. (Participant), Jēruma, A. (Participant), Zeltiņa, I. (Participant), Černušenko, A. (Participant), Ozere, I. (Participant) & Vanaga, I. (Participant)
15 Oct 2022Activity: Participating in or organising an event types › Participating in a conference, workshop, ...
-
Tuberculosis in Children: Prevention, Detection, Diagnosis, and Treatment According to the WHO Consolidated Guidelines on Tuberculosis; Module 5: Management of Tuberculosis in Children and Adolescents
Ozere, I. (Invited speaker)
6 Sept 2022 → 9 Sept 2022Activity: Talk or presentation types › Invited talk
-
TB diagnostika un ārstēšana bērniem
Ozere, I. (Speaker)
6 Apr 2022Activity: Talk or presentation types › Oral presentation
Press/Media
-
Kāpēc Austrumeiropu Covid-19 skāris vieglāk?' – infektologi par sākto prettuberkulozes vakcīnas pētījumu
29/04/20
1 item of Media coverage
Press/Media